Cannabinoids, Terpenes, and Flavonoids: A Plant-Chemistry Map
Cannabis sativa contains many kinds of chemical compounds. Cannabinoids, terpenes, and flavonoids are three different families within that larger chemistry. A label or laboratory report may describe one family without measuring the others.
The most reliable starting point is simple:
- a compound name identifies a chemical substance or family;
- a product-format name describes physical form;
- a laboratory result describes the identified sample and method; and
- a human-outcome claim requires evidence beyond chemical presence.
Finding CBD, limonene, or a flavonoid in plant material does not by itself establish what a retail product will do.
The three families at a glance
| Compound family | Examples found in cannabis literature | What a report may show | What presence alone does not establish |
|---|---|---|---|
| Cannabinoids | CBDA, CBD, THCA, delta-9 THC, CBGA, CBG, CBN, CBC | Individual analytes, concentration, total calculations, reporting limits | Effect, legality, safety, spectrum, or batch-wide uniformity |
| Terpenes and terpenoids | Myrcene, limonene, beta-caryophyllene, alpha-pinene, linalool | Named volatile compounds and concentration under a terpene method | A guaranteed aroma, experience, or therapeutic outcome |
| Flavonoids and other phenolics | Apigenin, luteolin, quercetin derivatives, cannflavin-related compounds | Only when a suitable targeted or broader chemical method includes them | That a standard cannabinoid or terpene panel measured them |
These categories can appear in the same plant, but they are not interchangeable. “Total cannabinoids” does not mean total terpenes or total plant compounds.
Cannabinoids
Phytocannabinoids are cannabinoid compounds produced by the plant. In living or freshly harvested plant tissue, many occur substantially in acidic forms, including CBGA, THCA, and CBDA. Neutral forms such as CBG, delta-9 THC, and CBD can arise through decarboxylation and other processes.
The acid and neutral forms are separate analytes. A laboratory can measure CBDA and CBD independently. It can also calculate a total value using a defined formula that accounts for the mass change associated with decarboxylation.
A cannabinoid panel may include:
- delta-9 THC and THCA;
- CBD and CBDA;
- CBG and CBGA;
- CBC and CBCA;
- CBN;
- THCV and THCVA;
- delta-8 THC; and
- other analytes within the method’s scope.
The list varies. A panel displaying twelve cannabinoids does not establish that every cannabinoid known to science was tested. An analyte absent from the table may be outside the method, not ordered, not reported, or covered elsewhere.
Named result versus calculated total
An individual result reports one analyte under the stated method. A calculated total combines specified acid and neutral results using a formula.
For total THC, a common calculation is:
total THC = delta-9 THC + (THCA × 0.877)
The factor accounts for the difference in molecular mass when THCA loses carbon dioxide during decarboxylation. The result is a calculated potential total under the stated convention; it is not a measurement of what happened to every molecule in the sample.
Total THC and THCA explains the calculation and its legal and analytical limits.
Cannabinoid abundance is not product identity
A high CBD result does not tell a reader whether the sample was flower, distillate, isolate, oil, or a finished edible. The matrix field supplies that context.
Likewise, a product name containing CBG or CBN does not establish its concentration. Match the current label, variant, batch or lot, sample ID, matrix, and report dates before using the result.
NIST’s RM 8210 Hemp Plant illustrates the precision required. It is a specifically prepared, ground, sieved, packaged, and characterized hemp reference material with assigned values for selected cannabinoids, moisture, and toxic elements. It is not a universal profile of hemp plants or retail products.
Terpenes and terpenoids
Terpenes are a broad family of compounds built from isoprene-derived units. In ordinary cannabis discussion, “terpene panel” may include compounds that chemists classify more specifically as terpenes or oxygen-containing terpenoids.
Commonly reported names include:
- alpha-pinene and beta-pinene;
- myrcene;
- limonene;
- linalool;
- beta-caryophyllene;
- humulene;
- terpinolene; and
- ocimene-related compounds.
The exact identity matters. Similar common names, stereoisomers, and analytical co-elution can complicate interpretation. A report should identify the method and analyte list rather than rely on a general “terpene-rich” statement.
Volatility changes the evidence
Many terpenes are volatile. Their measured profile can be affected by:
- plant tissue and maturity;
- harvest and post-harvest handling;
- drying;
- storage time;
- temperature;
- package seal;
- sample grinding or preparation; and
- analytical method.
The aroma perceived when a package is opened is therefore not a quantitative terpene test. Strong aroma does not prove a high total concentration, and a laboratory concentration does not guarantee what every person will perceive.
A terpene panel should be matched to the same batch and relevant matrix. A source-flower terpene report does not automatically describe an oil or gummy produced later.
Terpene names are not effect labels
Commercial descriptions often connect individual terpenes with mood, sleep, energy, pain, focus, or other outcomes. Chemical presence alone cannot support those promises.
Evidence would need to address the actual compound identity, amount, route, product mixture, population, comparator, endpoint, duration, and uncertainty. A trace value in a plant report cannot be converted into a human-effect claim by attaching a familiar terpene name.
Flavonoids and other phenolic compounds
Flavonoids are phenolic plant metabolites. They participate in plant biology and can contribute to pigmentation, protection, and interactions with the environment. Cannabis research has identified common plant flavonoids and cannabis-associated compounds including cannflavin-related molecules.
This category is chemically distinct from cannabinoids and terpenes. A compound can be aromatic in the everyday sense without being a terpene, and a colored plant component is not automatically a flavonoid.
Flavonoids are usually not listed on routine retail cannabinoid COAs. Their absence from the report does not prove absence from the material; it often means the panel did not measure them.
To support a flavonoid result, a reader would need:
- the named analyte;
- a suitable method;
- reference standards or identification criteria;
- matrix validation;
- unit and reporting limit;
- sample and batch identity; and
- the complete result and qualifiers.
“Contains flavonoids” is a broad botanical statement. It is not a quantitative product specification.
The plant contains more than three families
Cannabis chemistry also includes fatty acids, amino acids, sugars, waxes, pigments, sterols, alkaloids, minerals, water, and many other constituents. Contaminants or processing residues can also be present without being natural plant metabolites.
This matters because “whole plant” and “full spectrum” can sound comprehensive while leaving the analytical scope undefined. No practical retail panel measures every molecule in a product.
Ask which compounds were intentionally targeted and which panels were actually performed.
Where compounds occur in the plant
Chemical distribution can differ among flowers, leaves, stems, roots, seeds, and surface structures. Glandular trichomes on aerial tissues are important sites for cannabinoid and terpene production and storage, but the plant is not chemically uniform.
Research that profiles one tissue, cultivar, growth condition, or harvest stage cannot be assumed to describe another. Even within one plant, different locations can produce different measurements.
That is why a botanical paper is not a batch COA. The paper may establish that a class has been observed in Cannabis sativa under its study conditions. The COA addresses the identified submitted sample under its analytical method.
Sampling Matters explains how selection controls the broader inference.
One sample can require several analytical panels
Different compound families often require different sample preparation, separation, detection, calibration, and reporting procedures.
A cannabinoid method may use liquid chromatography to separate and quantify selected acidic and neutral cannabinoids. A volatile-terpene method may use gas chromatography and a different extraction or headspace procedure. A flavonoid investigation may use another chromatographic method and standards for the particular phenolic compounds.
The presence of one page does not imply the others were performed.
| Report section | Questions it can answer | Questions it cannot answer without more evidence |
|---|---|---|
| Cannabinoid panel | Which listed cannabinoids were reported, in what units and at what limits? | Which terpenes, flavonoids, pesticides, metals, microbes, or solvents are present? |
| Terpene panel | Which listed volatile compounds were reported under the method? | Total cannabinoid content, clinical effect, or every aroma compound present? |
| Flavonoid or phenolic analysis | Which targeted phenolic compounds were identified or quantified? | Full-spectrum status, safety, or unmeasured plant chemistry? |
| Contaminant panel | Which specified contaminants were tested under its method? | The product's ingredients or complete natural-metabolite profile? |
When a seller provides separate pages, confirm that their sample IDs and batch identifiers match. A cannabinoid panel from one lot and terpene panel from another do not form one composite profile merely because the product names look similar.
What “spectrum” labels can and cannot say
Full spectrum, broad spectrum, and isolate are marketplace composition terms. They do not name standardized lists of cannabinoids, terpenes, and flavonoids that must appear at fixed amounts in every product.
A spectrum claim should be evaluated against:
- the product's ingredient statement;
- the manufacturing description that the business can substantiate;
- a matched finished-product cannabinoid panel;
- applicable detection and quantification limits;
- any terpene or other panel actually performed; and
- the meaning assigned to the term on that product.
“Full spectrum” does not prove that every native plant compound survived processing. “Broad spectrum” does not reveal which compounds remain. “Isolate” does not establish mathematical purity or absence of every other analyte.
Full Spectrum, Broad Spectrum, and Isolate shows the evidence needed for each label.
Format changes the chemistry question
Flower
Flower retains plant tissue and can contain acidic cannabinoids, neutral cannabinoids, volatile compounds, pigments, waxes, water, and other constituents. The profile varies by batch and storage history.
A flower COA may report cannabinoids and perhaps terpenes. That does not mean flavonoids or every volatile compound were tested. Appearance and aroma remain observations, not a substitute for chemical analysis.
Oil
An oil is a formulation. It can contain a hemp-derived ingredient plus a carrier oil and other declared ingredients. The finished oil's chemistry may differ from the source extract because of dilution, blending, oxidation, settling, or added ingredients.
The label should distinguish bottle volume, named cannabinoid amount, carrier, and any flavor ingredients. A source-extract COA cannot automatically verify the finished bottle concentration.
Distillate and other extracts
Distillate is a refined extract, not a fixed chemical profile. Its dominant cannabinoid, minor constituents, residual solvents, and physical behavior require batch evidence. A high cannabinoid percentage does not prove the material is an isolate.
Isolate
An isolate is intended to be a separated compound-rich material. The named cannabinoid and reported purity remain batch-specific measurements. A 1 g package describes material mass, not automatically 1 g of the named cannabinoid.
Gummies and capsules
These are multi-ingredient finished products. A cannabinoid ingredient is only one part of the formulation. The ingredient list, per-piece or per-capsule label, count, and matched finished-product result answer different questions.
Plant-compound language should not obscure sugars, carriers, capsule materials, flavors, colors, or other active ingredients.
Total values do not create a complete profile
A report may display “total cannabinoids” or “total terpenes.” Read the calculation note before using the total.
Questions include:
- Which individual results are included?
- Are non-detects treated as zero?
- Are acidic forms converted with molecular-weight factors?
- Are values below LOQ included?
- Are the units consistent?
- Is the total measured directly or calculated?
- Does rounding occur before or after summation?
Two laboratories can produce different totals from the same individual analytes if their inclusion and rounding rules differ.
The total also hides composition. Ten milligrams per gram distributed among several analytes is not the same profile as ten milligrams per gram of one analyte.
“Entourage” is a hypothesis, not a batch result
The word “entourage” is often used to suggest that combinations of cannabinoids, terpenes, or flavonoids produce effects that differ from isolated compounds.
Chemical co-occurrence does not demonstrate synergy. To test an interaction, research would need defined compounds and amounts, appropriate comparators, controlled conditions, outcomes, and analysis designed to distinguish the mixture from its components.
A multi-analyte COA proves neither synergy nor antagonism. It reports chemical measurements for the identified sample.
The term should therefore not be used as shorthand for “better,” “more effective,” or “therapeutic.” A product can contain multiple reported compounds without clinical evidence for the product's claimed outcome.
Aroma, color, and texture are limited clues
Sensory observations can help identify a changed or damaged product, but they do not reveal a complete chemical profile.
- Citrus-like aroma does not quantify limonene.
- Purple plant tissue does not establish a particular flavonoid concentration.
- Visible trichomes do not supply a cannabinoid percentage.
- Crystal formation does not prove chemical purity.
- Thick viscosity does not identify a distillate's cannabinoid content.
Laboratory measurement and physical observation should be recorded separately.
Natural occurrence, addition, and conversion are different facts
A compound name on a result does not reveal how it came to be present.
It may have:
- occurred in the source plant;
- formed during storage or processing;
- been concentrated through separation;
- been added as an ingredient;
- been converted from another compound; or
- arisen through degradation.
Establishing origin requires process, ingredient, supplier, and batch records—not just a chromatogram. This distinction becomes particularly important when laws define naturally occurring, converted, or synthetic cannabinoids differently.
No IHF product should be assigned a manufacturing origin or conversion pathway unless verified records support it.
Chemical presence is not a legal conclusion
Federal and state laws can define hemp, marijuana, THC classes, synthetic substances, finished products, or intoxicating cannabinoids using different language and dates.
A laboratory result is an input to legal analysis. It does not decide:
- which statute applies;
- whether a compound falls within a legal definition;
- which total must be calculated;
- whether a container threshold applies;
- whether an exemption or product restriction applies; or
- whether a state rule differs from federal production law.
Federal Hemp Law in 2026 separates the current definition from the November 12, 2026 change. Legal status should be verified for the jurisdiction, product, date, and governing text.
Chemical presence is not a safety conclusion
A cannabinoid, terpene, or flavonoid panel is not a complete safety assessment. It may not address contaminants, dose, route, interactions, allergens, vulnerable populations, package integrity, or use conditions.
Likewise, a contaminant panel covers only the analytes, methods, and limits shown. “Passed” under one program does not create a universal guarantee.
Health questions belong with qualified clinicians and reliable regulatory information. Product pages and plant-chemistry articles should not supply individualized advice.
A five-record reading sequence
When a product uses plant-chemistry language, compare five records:
- Current label: product identity, ingredients, net quantity, cannabinoid statements, warnings, and batch code.
- Selected variant: exact size, strength, count, flavor, or format.
- Matched COA: sample and batch identity, matrix, dates, methods, analytes, units, limits, and result qualifiers.
- Panel scope: which compound and contaminant families were actually tested.
- Current law: definitions and requirements for the product, jurisdiction, and date.
If the label says “terpene-rich” but no terpene panel is supplied, the phrase remains an unverified composition statement. If the COA lists CBD but the package lot differs, the numerical result is not matched evidence for that package.
Questions that expose the evidence boundary
- Is the term a compound, family, format, or marketplace label?
- Is the claim qualitative or quantitative?
- Which batch and matrix were tested?
- Which individual analytes appear?
- Which relevant analytes are absent from the method?
- Are values measured or calculated?
- What are the units, LOD, and LOQ?
- Were cannabinoid, terpene, flavonoid, and contaminant panels separate?
- Does the claim describe chemistry, sensory observation, legal status, or a human outcome?
- What additional evidence would the broader claim require?
The map becomes useful when it keeps categories apart. Cannabinoids are not terpenes. Terpenes are not flavonoids. A panel is not a complete profile, and a chemical profile is not a promise.